Feigal sees report on CDRH (Center for Devices and Radiological Health) as supportive of contracting out
This article was originally published in Clinica
Executive Summary
A review of the quality of science used to make decisions at the FDA's device centre, the Center for Devices and Radiological Health (CDRH), is set to fuel the debate on the need for the agency to make greater use of outside contractors. A panel of outside experts headed by the prestigious bioengineer, Robert Nerem, from the Georgia Institute of Technology, concluded that there are gaps in the scientific expertise at the CDRH.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.